About SynderBio

Developer of cancer diagnostic technology designed to isolate and enrich malignant cancer cells. The company's technology represents a new rapid and label-free approach to isolate and enrich malignant cancer cells from biological specimens in which there is a mixture of cancer and non-cancerous cells, enabling doctors and oncologists to lower pathology laboratory costs and provide fast diagnosis and treatment to the patients.